ArticleClinicoEconomics and outcomes research : CEOR2015

Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients.

S Grau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.